C4 glomerulopathy epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
Norina Usman (talk | contribs) (→Age) |
Norina Usman (talk | contribs) (→Race) |
||
Line 14: | Line 14: | ||
===Gender=== | ===Gender=== | ||
===Race=== | ===Race=== | ||
There is no racial predilection to C4 glomerulopathy. | |||
===Geographic Distribution=== | ===Geographic Distribution=== | ||
Revision as of 23:19, 2 August 2020
C4 glomerulopathy Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
C4 glomerulopathy epidemiology and demographics On the Web |
American Roentgen Ray Society Images of C4 glomerulopathy epidemiology and demographics |
Risk calculators and risk factors for C4 glomerulopathy epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Ali Poyan Mehr, M.D. [2]; Associate Editor(s)-in-Chief: Olufunmilola Olubukola M.D.[3]
Overview
Epidemiology and Demographics
Prevalence
Incidence
Age
Patients of all age groups may develop C4 glomerulopathy.
Gender
Race
There is no racial predilection to C4 glomerulopathy.